1. Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma An NRG Oncology/Gynecologic Oncology Group Study
- Author
-
Eskander, Ramez N, Ali, Shamshad, Dellinger, Thanh, Lankes, Heather A, Randall, Leslie M, Ramirez, Nilsa C, Monk, Bradley J, Walker, Joan L, Eisenhauer, Eric, and Hoang, Bang H
- Subjects
Reproductive Medicine ,Biomedical and Clinical Sciences ,Women's Health ,Cancer ,Clinical Research ,Uterine Cancer ,Genetics ,Rare Diseases ,Adaptor Proteins ,Signal Transducing ,Aged ,Biomarkers ,Tumor ,Blotting ,Western ,Carcinoma ,Endometrioid ,Chemokines ,Cohort Studies ,Endometrial Neoplasms ,Female ,Follow-Up Studies ,Humans ,Intercellular Signaling Peptides and Proteins ,Membrane Proteins ,Middle Aged ,Neoplasm Grading ,Neoplasm Recurrence ,Local ,Neoplasm Staging ,Prognosis ,Proto-Oncogene Proteins ,RNA ,Messenger ,Real-Time Polymerase Chain Reaction ,Reverse Transcriptase Polymerase Chain Reaction ,Survival Rate ,Tumor Cells ,Cultured ,Wnt Signaling Pathway ,Dkk3 ,SFRP1 ,SFRP4 ,Uterine cancer ,Wnt pathway ,Oncology and Carcinogenesis ,Oncology & Carcinogenesis ,Clinical sciences ,Oncology and carcinogenesis - Abstract
ObjectiveThe aim of the study was to determine the differential expression patterns of the wingless-type (Wnt) pathway inhibitors Dkk3 (Dickkopf 3), SFRP1 (secreted frizzled-related protein 1), and SFRP4 in normal müllerian tissue and endometrial endometrioid adenocarcinoma specimens.MethodsMessenger RNA (mRNA) and protein levels of the Wnt pathway inhibitors Dkk3, SFRP1, and SFRP4 were evaluated by real-time reverse transcription-polymerase chain reaction and Western blot analysis. A total of 87 human tissue specimens were obtained from 60 women who participated in Gynecologic Oncology Group protocol 210. Twenty-seven normal müllerian tissues, 32 early-stage, and 28 advanced-stage endometrial endometrioid cancer specimens were analyzed.ResultsMedian age for this cohort was 60 years, with median body mass index of 32 kg/m. There was a difference in Dkk3 protein expression between normal müllerian tissues and primary endometrial endometrioid adenocarcinoma samples (P = 0.05). There was down-regulation of Dkk3, SFRP1, and SFRP4 mRNA expression in patients with high-grade disease (P = 0.08, 0.06, and 0.05, respectfully). Furthermore, a decrease in SFRP1 and SFPR4 mRNA expression was noted in patients with a diagnosis of locoregional and distant disease recurrence. Lastly, a trend toward decreased progression-free survival in patients with low Dkk3, SFRP1, and SFRP4 mRNA expression levels was noted.ConclusionsWnt pathway inhibitor (Dkk3, sFRP1, and/or sFRP4) expression was down-regulated in patients with high-grade disease and was associated with locoregional and distant disease recurrence. Despite sample size (power) limitations, these results support previous preclinical studies and may suggest a therapeutic role for Wnt signaling in endometrial cancer.
- Published
- 2016